Hi all, I've been a PER holder since late 2020. Not as long as some but still a reasonable timeframe. There's one point I've never fully understood with respect to the results ANP achieved in the 2A pilot study. All 9 non-ambulant boys were treated with 1102 and we've all seen the beautiful table with green boxes showing improvement in nearly every measure taken. Question: are these results the average of all 9 boys? If so, did some participants see no improvement but their results were off-set by a few who had exceptional results? Can anyone clarify? It would be good if we knew the results for each of the nine participants, or results were communicated in a complete or partial response format.
- Forums
- ASX - By Stock
- PER
- Ann: Phase IIb study of ATL1102 in DMD completes recruitment
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-155
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $7.665K | 766.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3790595 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3172198 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 466665 | 0.011 |
2 | 3890595 | 0.010 |
7 | 5898144 | 0.009 |
3 | 1025000 | 0.008 |
3 | 1642854 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 466666 | 3 |
0.011 | 3153423 | 5 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
Last trade - 12.55pm 24/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |